middle.news
Entropy Neurodynamics Advances Controlled Psychedelic Therapy in Binge Eating Disorder Trial
9:38am on Tuesday 14th of April, 2026 AEST
•
Healthcare
Read Story
Entropy Neurodynamics Advances Controlled Psychedelic Therapy in Binge Eating Disorder Trial
9:38am on Tuesday 14th of April, 2026 AEST
Key Points
Third patient in TRP-8803 trial achieves full psychedelic response
Cohort 1 dosing nearing completion; Cohort 2 enrollment underway
Early data show multi-domain symptom improvements including binge severity and mood
TRP-8803 offers reproducible, controlled psychedelic effects via IV infusion
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Entropy Neurodynamics (ASX:ENP)
OPEN ARTICLE